VivaMed Biopharma
Submission Guidelines

What We Look For

VivaMed BioVentures evaluates in-silico drug inventions. Strong submissions are replicable, defensible, and commercially viable.

6 Months
Evaluation Period
10%
Revenue Share
$1M
Maximum Payout

Most submissions do not result in payment. See Program Rules for details.

The Bar: "Replicable and Defensible"

Strong submissions are not just ideas. They're replicable (a third party can rerun your analysis) and defensible (there's a plausible IP strategy and a clear clinical edge).

Clear clinical edge (efficacy, safety, tolerability, convenience)
Mechanism clarity (why this target/MoA, what evidence)
Reproducibility (data inventory + exact commands + environment)
IP pathway (what's novel, what claim type fits)

Invention Types We Like

De novo molecules

Novel chemotypes with credible binding hypothesis + property plan

Repurposing

New indications for existing drugs with strong mechanistic evidence

Biobetters

PK/PD improvements (half-life extension, reduced immunogenicity, better route)

Formulations / route innovation

Delivery strategy with measurable clinical benefit

Combinations

Rationale + quantified synergy and differentiation from standard-of-care

High-Value Claim Types

We're looking for inventions that map cleanly to patentable claim sets:

  • 1
    Composition of matter: novel small molecules, chemotypes, stereoisomers, salts, polymorphs, deuterated analogs
  • 2
    Prodrugs: linker/trigger concepts with clear, non-obvious benefit
  • 3
    Method of use: new indication/population/dosing backed by computational evidence
  • 4
    Formulations & route: SR/ER, depot, transdermal, inhaled, SC conversion
  • 5
    Biologics / biobetters: Fc engineering (YTE/LS), multispecifics, half-life extension

What "Good" Looks Like (Checklist)

One-paragraph abstract (claim, target disease, differentiator)
Evidence package: docking/MD, network inference, genetics, ADMET
Negative controls: tried alternatives and why this wins
Prior-art map: what's known, what's different
Reproducible repo: README + commands + environment + pinned dependencies

AI Disclosure (Required)

AI tools are allowed, but you must disclose them and document human inventive contribution (AI cannot be an inventor). Minimum requirements:

  • Tools + versions (models, platforms, checkpoints)
  • Prompt / output logs (with secrets redacted)
  • Human contribution narrative: what you conceived/decided/validated
  • Data provenance: what data was used, licenses, citations

What We Don't Accept

PHI/PII, secrets, credentials, or any sensitive personal data
Controlled / dual-use enabling details (select agents/toxins, export-controlled)
Previously published enabling detail that damages patent rights
Black-box claims without reproducibility, data lineage, and validation plan
Submissions where you're unwilling to allow VivaMed to retain data for internal R&D

Ready to Submit?

Start the intake form or review the full program rules before proceeding.

Submit Your InventionRead Program Rules